MedPath
FDA Approval

Morphine Sulfate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
PAI Holdings, LLC
DUNS: 044940096
Effective Date
October 4, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Morphine(100 mg in 5 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Morphine Sulfate

Product Details

NDC Product Code
0121-0825
Application Number
ANDA206573
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
October 4, 2023
MorphineActive
Code: X3P646A2J0Class: ACTIBQuantity: 100 mg in 5 mL
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSLClass: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86KClass: IACT
GLYCERINInactive
Code: PDC6A3C0OXClass: IACT
SODIUM BENZOATEInactive
Code: OJ245FE5EUClass: IACT
SORBITOLInactive
Code: 506T60A25RClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
TRISODIUM CITRATE DIHYDRATEInactive
Code: B22547B95KClass: IACT
© Copyright 2025. All Rights Reserved by MedPath